English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2530664      線上人數 : 254
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/6346


    題名: 抗不整脈氧基小蘗鹼類似物之合成研究
    Synthesis of 8-Oxoberberine Analogues as Potential Antiarrhythmic Agents
    作者: 單佩文
    Shan, Pei-Wen
    貢獻者: 藥學研究所
    關鍵詞: 抗心律不整藥物
    小蘗鹼
    8-氧基小蘗鹼
    Cannizzaro機轉反應
    8-oxoberberine
    antiarrhythmic agents
    berberine
    Cannizzaro mechanism
    日期: 1986
    上傳時間: 2009-09-11 16:52:18 (UTC+8)
    摘要: 中 文 摘 要 抗不整脈藥物氧基小蘗鹼類似物之合成研究 8-氧基小蘗
    鹼(JKL 1073A)(2)是一個小蘗鹼(1)的衍生物,初步藥理實驗中發現其具
    有加強心臟收縮力及減緩心跳具有抗不整脈的作用,並對於缺氧及
    ouabain所引起的心律不整有改善的作用;為了進一步了解其化學結構與
    抗心律不整作用之間的相關性,我們使用化學合成方法製備了數種氧基小
    蘗鹼衍生物,以供藥理實驗測定之用。化學合成方法是以四級化原小蘗鹼
    型衍生物之鹽類作為關鍵性中間化合物,加入30% NaOH水溶液進行類似
    Cannizzaro機轉的反應,得到七種8-氧基原小蘗鹼衍生物分別為化合物2,
    14, 17, 58, 59, 60, 61, 63及64。取化合物2及58,於鹽酸水溶液中加
    熱進行O-demethylation反應,得到化合物63及64。第十三位氧化的原小
    蘗鹼衍生物也同時被製備,主要是利用小蘗鹼氯鹽(1)作為起始原料,先
    經NaBH4還原作用形成dihydroberberine(15),再以m-chloroperbenzoic
    acid氧化,即可得到第十三位氧化的berberinephenolbetaine(26),以此
    作為一重要的中間產物,當使用1-propanol為溶媒並以NaBH4還原時,可
    以得到ophiocarpine(20)及epiophiocarpine(21)兩種產物;若
    berberinephenolbetaine(26)分別與鹽酸甲醇溶液或甲基碘試劑反應,則
    得到13-hydroxyberberinium Chloride(65)或13-methoxyberberinium
    iodide(66)二種產物。以化學合成的十三種化合物均經紅外光譜、氫光譜
    、碳光譜及質譜等光譜分析鑑定結構。部份包含中間產物的二十個化合物
    是以大白鼠之離體心臟作有關心收縮力與心跳速率之藥理活性測試。結果
    顯示化合物15及66可增加心收縮力和減緩自發性的右心房心跳速率,作用
    較JKL 1073A(2)為佳;而化合物54則是在加強右心室心收縮力方面比JKL
    1073A(2)更強。後續部份化合物有關其抗心律不整的藥理活性,目前正在
    評估測試中。
    AbstractSynthesis of 8-Oxoberberine Analogues as Potential
    Antiarrhythmic Agents 8-Oxoberberine (JKL 1073A) (2) is a analog
    of berberine(1), exhibited a positive inotropic effect and
    negative chronotropic effect. Besides the positive inotropic
    effect, it also possessed antiarrhythmic activity against
    cardiac arrhythmia induced by ouabain and hypoxia. Therefore,
    several analogues modeled after 8-oxoberberine (2) were prepared
    by chemical synthesis in order to evaluate the relationship
    between their structures and antiarrhythmic activity.
    Protoberberinium salts were used as key intermediates. Treatment
    of protoberberinium salts with 30% NaOH in aqueous solution, by
    the Cannizzaro mechanism, to yield seven 8-oxoprotoberberine
    derivatives 2, 14, 17, 58, 59, 60 and 61. O-Demethylation of
    compounds 2 and 58 with hydrochloric acid afforded the phenolic
    compounds 63 and 64.13-Oxygenated protoberberines were also
    perpared berberine chloride were reduced by NaBH4 to give
    dihydroberberine (15). Oxidation of dihydroberberine (15) by m-
    chloroperbenzoic acid gave berberine phenolbetaine (26) and
    following by NaBH4 reduction in 1-propanol to yield
    ophiocarpine(20) and epiophiocarpine(21). Reaction of
    berberinephenolbetaine(26) with hydrochloride or methyl iodide,
    gave the 13-hydroxyberberinium chloride(65) or
    13-methoxyberberinium iodide(66). The structures of these
    synthetic analogues are consistent with the spectral data of IR,
    PMR, CMR and Mass spectra.Twenty compounds including
    intermediates were evaluated with the isolated heart preparation
    from rats to determine the chronotropic and inotropic effects.
    The result indicated that compounds 15 and 66 have stronger
    effects in postive inotropic and negative chronotropic
    activities than that of JKL 1073A 2. Compound 54 showed more
    potent in positive inotropic effect than that of JKL 1073A 2 in
    right ventricle preparation.The evaluation of some other
    synthetic analogues on the isolated heart preparation is under
    investigated.
    資料類型: thesis
    顯示於類別:[藥學系] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc30KbMicrosoft Word108檢視/開啟
    摘要.pdf68KbAdobe PDF139檢視/開啟
    摘要.ppt137KbMicrosoft Powerpoint104檢視/開啟
    摘要.ps393KbPostscript74檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋